ALDRIGHETTI, LUCA ANTONIO MARIA
 Distribuzione geografica
Continente #
AS - Asia 21.471
EU - Europa 18.891
NA - Nord America 17.795
SA - Sud America 5.965
Continente sconosciuto - Info sul continente non disponibili 1.593
AF - Africa 495
OC - Oceania 31
AN - Antartide 1
Totale 66.242
Nazione #
US - Stati Uniti d'America 16.799
RU - Federazione Russa 10.860
SG - Singapore 8.171
CN - Cina 5.702
BR - Brasile 4.848
HK - Hong Kong 2.738
IT - Italia 2.434
VN - Vietnam 2.155
SE - Svezia 1.573
FR - Francia 1.012
BD - Bangladesh 1.005
DE - Germania 756
CA - Canada 418
AR - Argentina 405
FI - Finlandia 397
GB - Regno Unito 365
IN - India 345
IE - Irlanda 312
RO - Romania 288
MX - Messico 241
EC - Ecuador 228
AT - Austria 225
ID - Indonesia 209
IQ - Iraq 163
ZA - Sudafrica 150
JP - Giappone 148
NL - Olanda 146
CO - Colombia 123
PL - Polonia 120
ES - Italia 109
TR - Turchia 105
PY - Paraguay 95
VE - Venezuela 93
MA - Marocco 88
PK - Pakistan 86
UA - Ucraina 77
CL - Cile 74
MY - Malesia 74
JM - Giamaica 72
UZ - Uzbekistan 71
SA - Arabia Saudita 62
EG - Egitto 53
KE - Kenya 50
NP - Nepal 48
CR - Costa Rica 46
TN - Tunisia 45
AE - Emirati Arabi Uniti 44
HN - Honduras 44
LT - Lituania 43
PE - Perù 43
PH - Filippine 39
UY - Uruguay 33
AZ - Azerbaigian 32
DZ - Algeria 32
NI - Nicaragua 29
AU - Australia 26
DO - Repubblica Dominicana 26
JO - Giordania 26
KR - Corea 26
GT - Guatemala 24
KZ - Kazakistan 24
CH - Svizzera 23
TT - Trinidad e Tobago 23
IL - Israele 22
IR - Iran 21
OM - Oman 20
TH - Thailandia 18
BE - Belgio 17
BH - Bahrain 16
LB - Libano 14
SV - El Salvador 14
TW - Taiwan 14
AL - Albania 13
BO - Bolivia 13
BY - Bielorussia 13
PA - Panama 13
BB - Barbados 12
GR - Grecia 11
SK - Slovacchia (Repubblica Slovacca) 11
A1 - Anonimo 10
HU - Ungheria 10
NO - Norvegia 10
PR - Porto Rico 10
CZ - Repubblica Ceca 9
ET - Etiopia 9
PS - Palestinian Territory 9
RS - Serbia 9
AO - Angola 8
CI - Costa d'Avorio 8
KG - Kirghizistan 8
SY - Repubblica araba siriana 8
XK - ???statistics.table.value.countryCode.XK??? 8
BS - Bahamas 7
CG - Congo 7
KH - Cambogia 7
LY - Libia 7
MD - Moldavia 7
SN - Senegal 7
GE - Georgia 6
KW - Kuwait 6
Totale 64.533
Città #
Dallas 3.882
Singapore 3.789
Hong Kong 2.707
Moscow 2.361
San Jose 2.223
Ashburn 1.675
Council Bluffs 1.086
Shanghai 1.083
Hefei 986
Ho Chi Minh City 844
Lauterbourg 832
Princeton 742
Lawrence 740
Beijing 620
New York 493
Milan 487
Hanoi 438
Santa Clara 403
Los Angeles 370
São Paulo 357
Helsinki 312
Dublin 306
Rome 292
Phoenix 267
Nuremberg 234
Rio de Janeiro 152
Orem 134
Boardman 130
Munich 117
Da Nang 113
Vienna 110
Warsaw 105
Chicago 102
Belo Horizonte 96
Tokyo 96
Brasília 94
Montreal 92
Atlanta 90
Brooklyn 90
Naples 87
Mexico City 85
London 84
Frankfurt am Main 82
Houston 81
Toronto 81
Curitiba 78
Guayaquil 78
Chennai 77
Quito 77
Guangzhou 76
Johannesburg 74
Bologna 73
Haiphong 72
Denver 71
Campinas 69
Stockholm 69
Buffalo 68
Tashkent 66
Baghdad 63
Porto Alegre 63
Biên Hòa 59
Poplar 57
Boston 55
Salvador 51
Seattle 51
Guarulhos 50
Mumbai 49
Philadelphia 49
Cesano Boscone 46
San Francisco 46
Amsterdam 45
Manchester 44
Turin 44
Lappeenranta 43
Brescia 42
Dhaka 40
Kingston 40
Kuala Lumpur 40
Memphis 40
San José 40
Jakarta 39
Nairobi 39
Turku 39
Washington 39
Buenos Aires 38
Santo André 38
Fortaleza 37
Thái Bình 37
Hải Dương 36
Ribeirão Preto 36
Tianjin 36
Goiânia 35
Miami 35
Shenzhen 35
Can Tho 34
Florence 34
Manaus 33
Recife 33
Baku 32
Omaha 32
Totale 32.272
Nome #
111In-octreotide SPECT in occult carcinoid tumors 1.412
A prognostic model for use before elective surgery to estimate the risk of postoperative pulmonary complications (GSU-Pulmonary Score): a development and validation study in three international cohorts 336
In vivo macrophage engineering reshapes the tumor microenvironment leading to eradication of liver metastases 205
Endoscopic ultrasound-guided choledochoduodenostomy versus hepaticogastrostomy combined with gastroenterostomy in malignant double obstruction (CABRIOLET_Pro): A prospective comparative study 195
[Clinical value of spleen autograft]. FT Considerazioni sul valore clinico dell'autoinnesto di milza 193
Revealing and harnessing CD39 for the treatment of colorectal cancer and liver metastases by engineered T cells 186
Recommendations for laparoscopic liver resection: A report from the second international consensus conference held in morioka 186
[Conservative treatment of postoperative pancreatic fistula. Role of interventional radiology]. FT Trattamento conservativo della fistola pancreatica postoperatoria. Ruolo della radiologia interventistica 180
. Il trapianto di isole pancreatiche come alternativa alla terapia sostitutiva insulinica intensiva nei pazienti affetti da diabete mellito di tipo 1: l'esperienza dell'Istituto Scientifico San Raffale di Milano 176
[Continuous 24-hour intragastric pH monitoring. A new model of interpretation]. FT La pHmetria endogastrica continua sulle 24 ore. Nuovo modello d'interpretazione 171
18 casi di incidentaloma della colecisti: analisi della casistica di un singolo centro 169
EUS-guided GastroEnterostomy for management of malignant Gastric Outlet Obstruction: a prospective cohort study with matched comparison with Enteral Stenting 165
A comparison between robotic, laparoscopic and open hepatectomy: A systematic review and network meta-analysis 165
"Technological" approach versus clamp crushing technique for hepatic parenchymal transection: A comparative study 162
Chromatin Velocity reveals epigenetic dynamics by single-cell profiling of heterochromatin and euchromatin 161
A machine learning predictive model for recurrence of resected distal cholangiocarcinoma: Development and validation of predictive model using artificial intelligence 159
A comprehensive preoperative predictive score for post-hepatectomy liver failure after hepatocellular carcinoma resection based on patient comorbidities, tumor burden, and liver function: the CTF score 157
[Intestinal occlusion in cocaine-packet ingestion]. FT L'occlusione intestinale nella cocaine-packet ingestion 157
Liver Histology Predicts Liver Regeneration and Outcome in ALPPS: Novel Findings From A Multicenter Study 155
[Impact of preoperative locoregional chemotherapy with fluorodeoxyuridine on the outcome of liver resection]. FT Impatto della chemioterapia locoregionale preoperatoria con fluorodesossiuridina (FUDR) sulla chirurgia resettiva epatica 155
A Composite Endpoint of Liver Surgery (CELS): Development and Validation of a Clinically Relevant Endpoint Requiring a Smaller Sample Size 154
30 cases of "two stage hepatectomy” for liver metastases from colorectal cancer: a single centre experience 153
[Advanced age as risk factor in liver resection surgery]. FT L'eta avanzata come fattore di rischio nella chirurgia resettiva epatica 153
[Is the surgical treatment of spontaneous bacterial peritonitis still up-to-date?]. FT Trattare chirurgicamente la peritonite batterica spontanea e ancora attuale? 153
[Prognostic factors for long-term outcome of hepatic resection for colorectal liver metastases]. FT Fattori prognostici dell'outcome a lungo termine della chirurgia resettiva epatica per metastasi da carcinoma colorettale 153
Single-Center Retrospective Study Comparing Double Vein Embolization via a Trans-Jugular Approach with Liver Venous Deprivation via a Trans-Hepatic Approach 152
Liver Resection vs Nonsurgical Treatments for Patients With Early Multinodular Hepatocellular Carcinoma 147
[Role of totally implantable systems for long-term vascular access in the treatment of the neoplastic patient]. FT Ruolo dei sistemi totalmente impiantabili per accesso vascolare a lungo termine nel trattamento del paziente neoplastico 146
Preoperative and postoperative predictive models of early recurrence for colorectal liver metastases following chemotherapy and curative-intent one-stage hepatectomy 144
Proposed modification of the eighth edition of the AJCC staging system for intrahepatic cholangiocarcinoma 144
Benchmarks in Liver Resection for Intrahepatic Cholangiocarcinoma 142
A “cui prodest” evaluation on the development of a minimally invasive liver surgery program: a differential benefit analysis of open and laparoscopic approach for left and right hemihepatectomies 140
[Multimodal approach to rectal carcinoma with hepatic metastasis]. FT Approccio multimodale al carcinoma del retto con metastasi epatica 139
Comparing Liver Venous Deprivation and Portal Vein Embolization for Perihilar Cholangiocarcinoma: Is It Time to Shift the Focus to Hepatic Functional Reserve Rather than Hypertrophy? 137
Impact of body mass index on the prognosis of unresectable HCC patients receiving first-line Lenvatinib or atezolizumab plus bevacizumab 136
[Hepatic resection of metastasis of colorectal carcinoma: analysis of long-term prognostic factors of outcome]. FT Resezioni epatiche per metastasi da carcinoma colorettale: analisi dei fattori prognostici di outcome a lungo termine 135
Laparoscopic versus open liver resection for large (≥ 5 cm) hepatocellular carcinoma in elderly patients: a multicenter propensity score-matched study 134
A Prognostic Model To Predict Survival After Recurrence Among Patients With Recurrent Hepatocellular Carcinoma 131
Clinical Outcomes After Progression on First-Line Therapies in IDH1 Mutated Versus Wild-Type Intrahepatic Cholangiocarcinoma Patients 131
Atezolizumab plus bevacizumab versus Lenvatinib for patients with Barcelona clinic liver cancer stage B (BCLC-B) hepatocellular carcinoma (HCC): A real-world population 126
Preoperative MRI radiomic analysis for predicting local tumor progression in colorectal liver metastases before microwave ablation 126
Role of the prognostic nutritional index in predicting survival in advanced hepatocellular carcinoma treated with atezolizumab plus bevacizumab 125
Durvalumab Plus Gemcitabine and Cisplatin Versus Gemcitabine and Cisplatin in Biliary Tract Cancer: a Real-World Retrospective, Multicenter Study 125
Perioperative and Long-Term Outcome for Intrahepatic Cholangiocarcinoma: Impact of Major Versus Minor Hepatectomy 125
Adverse events as potential predictive factors of activity in patients with advanced hepatocellular carcinoma treated with lenvatinib 124
Analyzing the interaction between time to surgery and tumor burden score in hepatocellular carcinoma 121
Evaluation of the ACS NSQIP Surgical Risk Calculator in Elderly Patients Undergoing Hepatectomy for Hepatocellular Carcinoma 121
The failure to rescue factor: aftermath analyses on 224 cases of perihilar cholangiocarcinoma 119
Microwave ablation of liver malignancies: comparison of effects and early outcomes of percutaneous and intraoperative approaches with different liver conditions 119
Predicting futility of upfront surgery in perihilar cholangiocarcinoma: Machine learning analytics model to optimize treatment allocation 119
Combined hepatocellular-cholangiocarcinoma: morpho-molecular updates and considerations 118
Atezolizumab plus bevacizumab versus lenvatinib for unresectable hepatocellular carcinoma: a large real-life worldwide population 117
Minimally invasive approach for liver resections in patients with hepatocellular carcinoma and Child-Pugh B cirrhosis: shifting the paradigm? Long-term Outcomes from an International Multicentre Study 117
Combined Loco-Regional and Systemic Treatment Strategies for Hepatocellular Carcinoma: From Basics to New Developments 117
HER2 Pathway in Biliary Tract Cancer: A Snapshot of the Current Understanding and Future Directions 117
“Biological R2” resection for intrahepatic cholangiocarcinoma: identification of patients at risk for poor oncologic outcomes after curative-intent resection 116
Comparison between percutaneous and laparoscopic microwave ablation of hepatocellular carcinoma 116
An attempt to establish and apply global benchmarks for liver resection of malignant hepatic tumors 115
Thermal ablation versus surgical resection of small-size colorectal liver metastases (COLLISION): an international, randomised, controlled, phase 3 non-inferiority trial 115
Real-World Data on Ivosidenib in Patients with Previously Treated Isocitrate Dehydrogenase 1-Mutated Intrahepatic Cholangiocarcinomas: An Early Exploratory Analysis 115
Effects of pre-operative isolation on postoperative pulmonary complications after elective surgery: an international prospective cohort study 115
Perioperative Lymphopenia is Associated with Increased Risk of Recurrence and Worse Survival Following Hepatectomy for Hepatocellular Carcinoma 114
Application of hazard functions to investigate recurrence after curative-intent resection for hepatocellular carcinoma 112
Germline testing and genetic counseling in biliary tract cancer: an operative proposal to improve the state of art 112
Indocyanine green (ICG)-guided robotic resection for liver adenoma: combined technologies for precision surgery 112
Gemcitabine versus cisplatin, epirubicin, fluorouracil, and gemcitabine in advanced pancreatic cancer: a randomised controlled multicentre phase III trial 112
Harnessing CD39 for the Treatment of Colorectal Cancer and Liver Metastases by Engineered T Cells 111
E-AHPBA-ESSO-ESSR Innsbruck consensus guidelines for preoperative liver function assessment before hepatectomy 111
Cornerstones and divergencies in the implementation and use of liver hypertrophy techniques: results from a nationwide survey for the set-up of the prospective registry 110
Intermediate hepatocellular carcinoma: new horizons and prospects for our patients 110
The Impact of Postoperative Ascites on Survival After Surgery for Hepatocellular Carcinoma: a National Study 110
Workflow for high-dimensional flow cytometry analysis of T cells from tumor metastases 110
Combining Laparoscopic Liver Partitioning and Simultaneous Portohepatic Venous Deprivation for Rapid Liver Hypertrophy 109
Real-Life Clinical Data of Lenvatinib versus Sorafenib for Unresectable Hepatocellular Carcinoma in Italy 109
A stepwise learning curve to define the standard for technical improvement in laparoscopic liver resections: complexity-based analysis in 1032 procedures 108
Higher Postoperative Mortality and Inferior Survival After Right-Sided Liver Resection for Perihilar Cholangiocarcinoma: Left-Sided Resection is Preferred When Possible 107
Technique, complications, and therapeutic efficacy of percutaneous transplantation of human pancreatic islet cells in type 1 diabetes: the role of US 107
A Nomogram to Predict Long-term Survival After Resection for Intrahepatic Cholangiocarcinoma An Eastern and Western Experience 107
Harnessing CD39 for the treatment of colorectal cancer and liver metastases by engineered T cells 107
Perioperative and oncologic outcomes of open radical nephrectomy and inferior vena cava thrombectomy with liver mobilization and Pringle maneuver for Mayo III level tumor thrombus: single institution experience 107
Achievement of textbook outcome after hepatectomy combined with thermal ablation for colorectal liver metastases 107
Radial and longitudinal margins in surgery of perihilar cholangiocarcinoma: When R1 definition is associated with different prognosis 106
Navigator nurse implementation within a fast track program of liver resections: How to improve the healthcare service and perioperative results 106
Radioembolization for Hepatocellular Carcinoma: a Comparison on Dual-phase Cone-beam CT, Contrast-enhanced CT (CECT) and 99mTc-macroaggregated albumin-SPECT/CT in predicting final distribution volumes and dosimetry of the post-embolization 90Y PET/CT 106
Human pancreatic islets produce and secrete MCP-1/CCL2: relevance to human islet transplantation 106
Comparison of CMV reactivation after islet-kidney, pancreas-kidney or kidney alone transplantation in diabetic patients 106
Assessment of Textbook Outcome in Laparoscopic and Open Liver Surgery 106
Next-generation sequencing analysis of cholangiocarcinoma identifies distinct IDH1-mutated clusters 105
Retrospective Evaluation and Significance of Neutrophil-to-Lymphocyte Ratio Prior to and 1 month Following Microwave Ablation of Hepatocellular Carcinoma 105
Comparing practice and outcome of laparoscopic liver resection between high-volume expert centres and nationwide low-to-medium volume centres 105
Performance of comprehensive complication index and clavien‐dindo complication scoring system in liver surgery for hepatocellular carcinoma 105
The multi-societal European consensus on the terminology, diagnosis and management of patients with synchronous colorectal cancer and liver metastases: an E-AHPBA consensus in partnership with ESSO, ESCP, ESGAR, and CIRSE 104
The impact of recurrence timing and tumor burden score on overall survival among patients undergoing repeat hepatectomy for colorectal liver metastases 104
Factors Associated with and Impact of Open Conversion in Laparoscopic and Robotic Minor Liver Resections: An International Multicenter Study of 10,541 Patients 104
Impact of Tumor Size on the Difficulty of Laparoscopic Major Hepatectomies: An International Multicenter Study 103
Classification of Intrahepatic Cholangiocarcinoma into Perihilar Versus Peripheral Subtype 102
Robotic Major Hepatectomy in Elderly Patient 102
Impact of liver cirrhosis, severity of cirrhosis and portal hypertension on the difficulty of laparoscopic and robotic minor liver resections for primary liver malignancies in the anterolateral segments 102
Laparoscopic versus open resection for hepatocellular carcinoma according to the procedure's complexity: real-world weighted data from a national register 101
Durvalumab plus gemcitabine and cisplatin in advanced biliary tract cancer: An early exploratory analysis of real-world data 101
Totale 14.368
Categoria #
all - tutte 391.798
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 391.798


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022401 0 0 1 153 18 40 59 52 29 15 9 25
2022/20233.701 1.842 578 182 28 50 342 314 199 105 23 23 15
2023/20241.498 39 31 119 95 96 177 55 111 7 95 167 506
2024/202512.456 1.613 325 142 155 267 986 1.642 1.081 2.370 1.904 875 1.096
2025/202642.383 2.611 3.697 4.689 6.017 2.787 1.098 3.288 2.724 10.072 2.380 1.416 1.604
2026/20275.115 1.689 2.698 728 0 0 0 0 0 0 0 0 0
Totale 66.242